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Background: In this study, four lung lesion scoring methods (Slaughterhouse Pleurisy Evaluation System [SPES],
Consolidation Lung Lesion Score [LLS], Image analyses [IA] and Ratio of lung weight/body weight [LW/BW]) were
compared for the assessment of the different pathological outcomes derived from an Actinobacillus pleuropneumoniae
(App) experimental infection model. Moreover, pathological data was coupled with clinical (fever, inappetence and
clinical score), production (average daily weigh gain [ADWG]) and diagnostic (PCR, ELISA and bacterial isolation)
parameters within the four infection outcomes (peracute, acute, subclinically infected and non-infected).
Results: From the 61 inoculated animals, 9 were classified as peracute (presence of severe App-like clinical signs and
lesions and sudden death or euthanasia shortly after inoculation), 31 as acutely affected (presence of App-like clinical
signs and lesions and survival until the end of the experiment), 12 as subclinically infected (very mild or no clinical signs
but App infection confirmed) and 9 as non-infected animals (lack of App-like clinical signs and lack of evidence of App
infection). A significant correlation between all lung lesion scoring systems was found with the exception of SPES score
versus LW/BW. SPES showed a statistically significant association with all clinical, production and diagnostic (with the
exception of PCR detection of App in the tonsil) variables assessed. LLS and IA showed similar statistically significant
associations as SPES, with the exception of seroconversion against App at necropsy. In contrast, LW/BW was statistically
associated only with App isolation in lungs, presence of App-like lesions and ELISA OD values at necropsy.
Conclusions: In conclusion, SPES, LLS and IA are economic, fast and easy-to-perform lung scoring methods that, in
combination with different clinical and diagnostic parameters, allow the characterization of different outcomes after
App infection.
Keywords: Actinobacillus pleuropneumoniae, Porcine pleuropneumonia, Experimental inoculation, Lung lesion scoring,
Bacteriology, PCRBackground
Actinobacillus pleuropneumoniae (App) is the aetiological
agent of porcine pleuropneumonia, a severe contagious
disease distributed worldwide. This disease is character-
ized by haemorrhagic necrotizing pneumonia and fibrin-
ous pleuritis, affecting mainly growing and finishing pigs
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unless otherwise stated.animals, three major clinical forms, namely peracute,
acute or chronic disease [2]. These different disease
presentations vary in severity depending on the age of the
animals, the infecting App serovar and specific bacterial
strain, environmental conditions, breeding genetic line
susceptibility, pig immune status and magnitude of the
exposure to the bacterium [1-4]. As a consequence, the
clinical evolution of an App infection outbreak in a pig
population might be very variable.
The main clinical signs observed in animals suffering
from an acute App outbreak are high fever, vomiting,td. This is an Open Access article distributed under the terms of the Creative
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creased respiratory rate, coughing/sneezing and dys-
pnoea) [1]. Animals with the peracute presentation may
show all these clinical signs for a very short period of
time, often overlooked under farm conditions, together
with a foamy bloody nasal or oral discharge just prior
death [2]. The animals that survive the acute phase of
the disease may become chronically infected, showing
little or no fever, mild coughing, inappetence and reluc-
tance to move. Moreover, there is a proportion of
animals that might remain infected without showing any
apparent clinical sign. These subclinically infected ani-
mals are considered carriers of the infection [5].
Presence of animals with different disease presenta-
tions within a batch makes the App infection diagnosis
challenging. In acute or peracute stages, presence of
App-compatible clinical signs and/or lesions (haemor-
rhagic necrotizing pneumonia and fibrinous pleuritis) is
usually sufficient to suspect from an App infection out-
break. However, other diagnostic techniques, such as
serology, PCR or bacterial isolation, are needed for the
detection of chronically or subclinically infected animals.
Presence and extension of App-compatible lesions can
be assessed by visual estimation or using computed
techniques (tomography, ultrasonography, sonography
or radiography) [3,6]. Computed techniques allow the
objective detection and quantification of lung lesions in
dead but also in living animals [3]. Although these tech-
niques can be excellent tools for experimental infections,
their use at farm or slaughterhouse environments is
limited because skilled personnel, specialized equipment
and anesthetization of animals are required.
Thus, the objective of this study was to compare four
economic and easy-to-perform lung lesion scoring methods
for the assessment of the pathological outcomes derived
from an App experimental infection. Moreover, these dif-
ferent outcomes were also characterized by means of clin-
ical, productive and diagnostic parameters.
Methods
Animals
One hundred and fifteen11-week-old conventional male
piglets were included in the study. The animals came
from a farm free from App, Mycoplasma hyopneumoniae
(M. hyopneumoniae) and porcine reproductive and re-
spiratory syndrome virus (PRRSV). These piglets were
used in 6 different App experimental inoculation trials
performed at Centre de Recerca en Sanitat Animal
(CReSA) Biosecurity Level 3 (BLS3) facilities. Experi-
mental protocol, management conditions, animal inclu-
sion criteria and personnel were the same in all 6 trials.
Therefore, data coming from all the 6 trials was merged
in the same database. Animal care and study procedures
were conducted in accordance with the guidelines ofGood Experimental Practice, under the approval of
the Ethics Commission in Animal Experimentation of
the Generalitat de Catalunya (Approved Protocol
number 5796). Humane endpoints are described in
the Additional file 1.
Before transportation to CReSA, selected animals were
confirmed to be negative by serology against all App sero-
vars (App Apx-IV Ab test, Idexx®) and M. hyopneumoniae
(Blocking ELISA, Mycoplasma hyopneumoniae ELISA®,
Oxoid, UK). Nasal swabs were tested by nested PCR
(nPCR) to rule out M. hyopneumoniae infection [7].
Inoculum preparation
App strain 4074 (SHOPE 4074, ATCC 27088; serovar 1,
kindly donated by Dr. Marcelo Gottschalk, University of
Montreal, Canada) was used to inoculate the animals.
Bacterial inocula were prepared from freshly streaked
chocolate-agar plates. After approximately 5 hours at
37°C and 5% CO2, the bacterial growth was resuspended
in commercial PBS to give an optical density of 0.09 at
660 nm (this suspension corresponded to approximately
108 CFU/mL). Bacterial concentration was confirmed
by dilution of inoculum and plating on chocolate agar
plates.
Experimental design
Once at CReSA facilities, animals were weighed and
randomly distributed into 2 groups based on their body-
weight. After one week of acclimatization, sixty one out
of the 115 pigs (mean of 10 pigs per experiment) were
intranasally challenged with a mean dose of 1.5x108
CFU of App strain 4074 in 1.5 mL (half amount inocu-
lated in each nostril). The remaining 54 (mean of 9
animals per experiment) pigs were inoculated with the
same amount and by the same route with phosphate
buffer saline (PBS). Control and App-inoculated animals
were housed in different isolated pens. Animals were
weighed and bled at challenge and necropsy days. After
challenge, rectal temperature and clinical conditions
were recorded twice per day. One week after challenge,
animals were euthanized (Dolethal, Laboratorios Veto-
quinol E.V.S.A.) At necropsy, App-like lesions such as
fibrinous/fibrous pericarditis, pleuritis and lung ab-
scesses/necrosis were evaluated. Moreover, lung lesions
were scored using four different systems (see below).
In addition, tonsilar and lung swabs and a portion of
bronchial lymph node were collected from each
animal. All the procedures conducted (weighting, sam-
pling, clinical signs assessment and necropsy) were
done always in the same order: firstly in control and
secondly in challenged pigs. These samples were trans-
ferred to the laboratory, where they were processed for
bacterial isolation (lung swabs) or PCR (tonsilar swab
and bronchial lymph node).
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innapetence
Animals were observed daily for respiratory effort and
behaviour, and were scored as following: score 0: no
signs of disease; score 1: increased breathing rate, occa-
sional coughing and mild depression; score 2: abdominal
breathing, usually lying down, standing when gentle
stimulated; score 3: regular coughing or holding up on
forelegs in a sitting position or markedly depressed or
reluctant to stand up and with an increased heart rate
(>110 beats per min); score 4: clinical score of 3 plus
deteriorating towards showing signs of severe dyspnoea.
Besides, appetite was daily scored as normal or abnormal.
Rectal temperature
Rectal temperature was registered twice per day (at 7 am
and 2 pm) from the challenge day onwards. Temperature
measurements were done before any other manipulation.
The evaluation of fever was established by means of a
numerical score: 0 (less than 39.5°C), 1 (between 39.5 and
40.5°C) and 2 (higher than 40.5°C). This classification was
modified from the one described by Moore et al. [8]. Ani-
mals scored 2 were considered to have an unequivocal
raise in body temperature.
Weight and average daily gain
Weight was recorded on challenge and necropsy days.
Average daily gain (ADG) was calculated as the weight
at necropsy minus the weight at challenge divided by the
days lapsed between them.
App lung lesion scoring systems
Four different lung lesion scores were calculated after
the extraction of the lung from the thorax and after the
removal of the larynx and heart.
Slaughterhouse Pleurisy Evaluation System (SPES)
Presence of App-like lesions was scored 0 (no lesions), 1
(pleural fibrous/fibrinous adherences between cranio-
ventral portions of cranial, medial and diaphragmatic
lobes or monolateral mild adherences at the ventral mar-
gin of a diaphragmatic lobe), 2 (adherences with slight
to moderate extensions into one of the diaphragmatic
lobes), 3 (as score 2; but bilateral; in one of the diaphrag-
matic lobes can be extensive) and 4 (severely extended
lesions, at least 1/3 of both diaphragmatic lobes) [9].
SPES is a subjective, fast and simple lung scoring system
that provides information on the presence, extension,
and localization of App-like lesions. This method is
frequently used at slaughterhouse [9,10], where the use
of other lung scoring system based on the schematic
representation or photographing the lesions or weighting
the lung is not feasible due to the speed or the structure
of the slaughter chain.Consolidation Lung Lesion Score (LLS)
This method is based on the representation of the area
showing lesions in a schematic map of the lung. In this
scheme, each pulmonary lobe is divided by a number of
triangles depending on the size of the lobe (7 for each
cranial and middle lobe, 19 for each diaphragmatic lobe
and 8 for the accessory one) [11]. The number of trian-
gles affected with lesions per lobe is multiplied per five
and divided by the number of triangles of each lobe
(those lobes entirely affected with these lesions would
have a score of 5). The maximum score of LLS is 35 (five
points per lobe) [3]. LLS is the lung scoring system
recommended by European Pharmacopoeia for testing
A. pleuropneumoniae vaccines upon challenge with the
bacterium [12]. This system is frequently used in experi-
mental inoculations with different pathogens or in nec-
ropsy sessions, when time and space to represent the
lung damage is available [13].
Image analyses (IA)
IA is an objective method that allows the quantification of
the affected lung area (%) by means of a picture and the
use of the corresponding software (in this particular study,
the ImageJ® online free software was used, http://rsbweb.
nih.gov/ij). For such analysis, a picture was taken from the
dorsal side of all studied lungs. The ventral side was
pictured when the lesions were present only in that side.
In order to obtain the percentage of affected lung, the area
affected by lesions and total areas of the dorsal side of
each lung were delimitated in each picture. All pictures
were evaluated to the same bit scale. The percentage of
affected area was obtained by the following formula:
Right lung affected area þ Left lung affected areað Þ=
Total lung area  100
This system allows having a photographic database of
the lesions and to calculate the damaged lung surface
when needed/desired. However, the need of a picture in
the same position and the same bit scale makes its use
at slaughterhouse very difficult.
Ratio of lung weight/body weight(LW/BW)
This is an objective method that allows the quantifica-
tion of the increased lung weight due to lesions with
respect to the whole weight of the pig. This ratio was
calculated using the following formula:
Weight of the lung=body weightð Þ  100:
App re-isolation
Lung swabs were streaked on chocolate-agar plates in
two sections in order to get isolated colonies. After over-
night incubation at 37°C and 5% CO2, bacterial growth
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was recorded and semi-quantified in the first section of
the plate as: 0, no growth; 1, 1-19 colonies; 2, 20-200
colonies; and 3, confluent growth. The highest quantifi-
cation of both sides of the lung was used to obtain the
total bacterial score.
App antibodies
Blood samples taken at challenge and necropsy were
tested with a commercial ELISA kit (Actinobacillus
pleuropneumoniae 1, 9, 11 Swinecheck® APP 1, 9, 11.
Biovet. Canada).
DNA extraction and App PCR detection
DNA from nasal and tonsilar swabs was extracted using
Nucleospin blood, while DNA from bronchial lymph
node was extracted with Nuclesopin tissues (both kits
from Macherey-Nagel). DNA from both samples was
tested by a nPCR that detects the APX IV gene, a toxin
produced by all App serovars [14].
Statistical analyses
All statistical analyses were carried out using the SAS
system V.9.1.3 (SAS institute Inc, Cary, NC, USA). For
all analyses, the individual pig was used as the experi-
mental unit. The significance level (p) was set at 0.05
with statistical tendencies reported when p < 0.10. Pres-
ence of App lung lesions (assessed by the different lung
scoring systems) and presence of App-like clinical signs
were considered the primary and secondary experimen-
tal outcomes. The variables included in the statistical
analyses were classified as dichotomous (mortality prior
the end of the study, fever, clinical score higher than 0,
inappetence, App re-isolation, presence of App-like le-
sions, seropositivity against 1, 9,11 App serovars, PCR in
tonsil and PCR in bronchial lymph node), ordinal (max-
imum clinical score and SPES scoring system) or con-
tinuous (ADG, number of days showing fever, number
of days showing inappetence, ELISA OD values at nec-
ropsy, LLS, IA and LW/BW). Shapiro Wilk’s and Levene
tests were used to evaluate the normality of the distribu-
tion of the continuous variables and the homogeneity of
variances, respectively. Two different statistical analyses
were performed to test the: 1) association between the
different variables with the four lung scoring systems,
and 2) association among the four different lung scoring
methods used. Contingency tables (Chi-square or Fischer
exact tests) were used when the association between
dichotomous and ordinal variables was assessed. To study
the association between dichotomous or ordinal variables
with the continuous non-normally distributed lung lesion
scoring, the Wilcoxon test (with the U Mann-Whitney
test to compare each pair of values) was used. To analyse
the association between continuous normally distributedvariables and dichotomous or ordinal variables, an
ANOVA test (with Student’s T-test to compare each
pair of values) was used. Finally, a linear or quadratic
regression analysis was performed to evaluate the
correlation between continuous variables.
Results
Clinical outcome
Control non-inoculated animals (n = 54) did not show
fever, were clinically scored 0 through the whole study
period and showed an ADG of 0.84 ± 0.20 Kg/d. In
contrast, among the App inoculated animals, different
severity of respiratory clinical signs (from 0 to 3) was
observed. On one hand, nine animals showed peracute
disease with fever, apathy, reluctance to move and (in
five of them) foamy bloody nasal discharge. From these
nine animals, five showed sudden death within the
24-36 h after the challenge and four were euthanized
(within the same period) for animal welfare reasons. On
the other hand, 39 animals survived until the end of the
study with different severity of clinical signs and/or
fever. Finally, 13 animals did not show either fever or
any apparent clinical sign (score 0) through the whole
study.
Pathological outcome
Control animals did not show any lesions at necropsy.
Lung lesions observed in the 9 animals that died shortly
after inoculation consisted of unilateral or bilateral
fibrino-haemorragic pleuropneumonia, with presence (in
some of them) of foamy and bloody mucus exudate in
the bronchi and trachea. In addition, 31 pigs showed uni-
lateral or bilateral fibrino-to-fibrous necrotizing pleurop-
neumoniae and 21 animals did not show any App-like
apparent lesions.
Lung lesions scoring results
Examples of lung lesions derived from the App serovar 1
intranasal inoculation and the corresponding value of
each scoring system used is given in Figure 1. Whereas
SPES, LLS and IA were done in 61 animals, LW/BW
was only performed in the 36 infected animals included
in the last three trials. Reference values for this ratio
LW/BW were provided by the control (non-inoculated)
animals included in each of these three trials (n = 33).
Ratio LW/BW was significantly higher in App inoculated
animals (1.15 ± 0.48) than in their control counterparts
(0.90 ± 0.202).
Relation between the four different lung scores with clinical
variables
The relationship between each lung lesion score with
the clinical dichotomous variables is detailed in Table 1.
Figure 1 Examples of the lung lesions observed in animals intranasally inoculated with App serovar 1 and the corresponding value for
the four lung lesions scoring systems used.
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with the four lung scoring systems is shown in Figure 2.
SPES, LLS and IA showed a statistically significant
association with mortality prior to the end of the experi-
ment, fever and inappetence (Table 1), as well as with
maximum clinical score (Figure 2). In addition, these
three scoring systems were also associated with the
number of days that the animals showed fever, number
of days with inappetence and number of days with clin-
ical score higher than 0 (data not shown). In contrast,
LW/BW showed only a statistical association with the
number of days showing fever, number of days showing
clinical score higher than 0 (data not shown) and atendency with the presence of inappetence (Table 1) and
the number of days with inappetence (data not shown).Relation between the four different lung scores with the
production variable ADG
SPES, LLS and IA showed a statistically significant asso-
ciation with ADG (Figure 3), while LW/BW did not.Relation between the four different lung scoring and the
diagnostic variables
Relationship between each lung scoring and the different
diagnostic dichotomous variables is detailed in Table 2.
Table 1 Mean values and range (Max-Min) of each lung
scoring system within each dichotomous clinical variable
Lung
score
Clinical variables
Mortality prior to the
end of the study Fever Inappetence
Yes No Yes No Yes No
SPES
3.8a 1.2b 1.7a 0.1b 2.3a 0.7b
(4-3) (4-0) (4-0) (1-0) (4-0) (3-0)
LLS
17.6a 3.1b 6.9a 0.1b 8.1a 1.4b
(31.4-10.7) (20.9-0) (31.5-0) (1.4-0) (31.5-0) (7.7-0)
IA
53.3a 10.9b 22.3a 0.6b 26.2a 5.3b
(88.4-34.1) (54.5-0) (88.4-0) (5.9-0) (88.4-0) (32.3-0)
LW/BW
0.9a 1.1a 1.2a 1.0a 1.4a* 1.0a*
(0.9-0.9) (2.3-0.1) (2.3-0.1) (1.4-0.7) (2.3-0.7) (1.7-0.1)
SPES: Slaughterhouse Pleurisy Evaluation System; LLS: Consolidation Lung
Lesion Score; IA: Image analyses; LW/BW: Ratio of lung weight/body weight.
Different letter in superscript means statistically significant differences within a
given clinical variable (p < 0.05).
*p = 0.07.
Sibila et al. BMC Veterinary Research 2014, 10:165 Page 6 of 10
http://www.biomedcentral.com/1746-6148/10/165SPES was statistically associated to all diagnostic vari-
ables but App PCR detection in tonsil. On the other hand,
LLS and IA were statistically associated to all diagnostic
variables but App PCR detection in tonsil (tendency) and
seropositivity against App at necropsy. Finally, LW/BW
was only statistically associated to App re-isolation and
presence of App-like lesions. In addition, LW/BW showed
a statistical tendency of association with App PCR detec-
tion in bronchial lymph node.
In addition, all the four lung lesion scores showed
an association with the ELISA OD values of the sera
obtained at necropsy (data not shown).0 1 2 3
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Figure 2 Representation of the mean lung lesion score (±SD) regardin
period. SPES: Slaughterhouse Pleurisy Evaluation System; LLS: Consolidation L
weight. Different letter in superscript means statistically significant differences wCorrelation among the four different lung scores
The correlation among the four lung scoring systems is
detailed in Table 3. A significant correlation between all
the lung lesion scoring systems was found with the
exception of the correlation between SPES and LW/BW
scores.
Characterization of the disease outcome
Evaluation of all the parameters described in the previ-
ous sections allowed the classification of the App inocu-
lated animals into four categories according to the
disease outcome displayed. A detailed description of the
parameters used to establish such classification, as well
as the statistical differences found between each cat-
egory, is given in Table 4.
The 9 animals that did not survive until the end of the
study were classified as peracutely affected animals. All
these animals showed App gross lesions (uni or bilateral
fibrino-necrotizing-haemorragic pleuropneumonia) and
in all cases App was re-isolated from the lung. Whereas
most of these animals were positive by PCR at tonsil (8/
9) and/or at bronchial lymph node (5/9), all of them
were seronegative against App at the moment of death.
The remaining 52 pigs were classified as acutely affected
(n = 31), subclinically infected (n = 12) and exposed but
uninfected (n = 9) animals. Acutely affected animals were
those that survived the initial phase of disease but
showed evident clinical signs (dyspnoea and cough,
fever, reduced appetite, and were reluctant to move). At
the end of the study, these animals showed unilateral or
bilateral fibrino-to-fibrous necrotizing pleuropneumo-
niae. All these animals (but one) were positive by cultureLL
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g the maximum clinical score displayed during the experimental
ung Lesion Score; IA: Image analyses; LW/BW: Ratio of lung weight/body
ithin a given variable (p < 0.05).
Figure 3 Mean average daily weigh gain (ADG) (Kg/day ± SD) within each lung scoring system. SPES: Slaughterhouse Pleurisy Evaluation
System; LLS: Consolidation Lung Lesion Score; IA: Image analyses; LW/BW: Ratio of lung weight/body weight. Different letter in superscript means
statistically significant differences within a given variable (p < 0.05).
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31 animals, 16 were seropositive against App 1,9,11
serovars at the moment of necropsy (7 dpi). Subclinically
infected animals were defined as those in which App
infection was confirmed (by re-isolation, PCR detection
or antibody detection at necropsy) but showed little or
no fever, mild or no clinical signs and did not show
App-like lesions. Seven out of these 12 animals were
seronegative and negative to App culture but positive by
PCR either at the tonsil and/or at the bronchial lymph
node. Finally, exposed but uninfected animals were those
that were inoculated, but App was neither detected byTable 2 Mean values and range (Max-Min) of each lung scorin
Lung
Score
Diagn
App Re-isolation Presence of App-likelesions
PCR in
sw
Yes No Yes No Yes
SPES
2.3a 0.1b 2.5a 0b 1.8a
(4-0) (1-0) (4-0) (4-0)
LLS
7.6a 0.1b 7.9a 0b 6.6a*
(31.4-0) (1.4-0) (31.4-0.2) (31.4-0)
IA
24.1a 0.2b 25.4a 0b 20.9a*
(88.3-0) (1.4-0) (88.3-0.6) (88.3-0)
LW/BW
1.2a 0.9b 1.3a 0.9b 1.1a
(2.3-0.1) (1.3-0.7) (2.3-0.1) (1.4-0.7) (2.0-0.1)
SPES: Slaughterhouse Pleurisy Evaluation System; LLS: Consolidation Lung Lesion Sc
letter in superscript means statistically significant differences within a given diagno
*p = 0.07; **p = 0.06.PCR nor re-isolated, did not show either App clinical
signs nor App-like lesions and no evidence of App sero-
conversion was observed at necropsy.
Discussion
The present work aimed to compare 4 different scoring
systems to evaluate lung lesions caused by App under
experimental settings, and to correlate them with a
number of clinical, productive and diagnostic parame-
ters. Moreover, such complete characterization allowed
classifying the animals in four different disease out-
comes. In addition, this detailed characterization of Appg system within each of dichotomous diagnostic variable
ostic variables
tonsilar
ab
PCR in bronchial
lymph node
Seropositivity to App 1,9,11
(at necropsy)
No Yes No Yes No
1.4a 2.3a 1.2b 1.9a 1.5b
(4-0) (4-0) (4-0) (4-0) (4-0)
3.1a* 7.6a 3.8b 4.6a 5.5a
(16.2-0) (20.9-0) (31.5-0) (16.3-0) (31.5-0)
12.4a* 24.1a 13.2b 14.9a 18.5a
(48.3-0) (65.5-0) (88.3-0) (42.1-0) (88.3-0)
1.3a 1.3a** 1.02a** 1.0a 1.3a
(2.3-0.7) (2.3-0.01) (2.3-0.7) (2.3-0.8) (2.3-0.1)
ore; IA: Image analyses; LW/BW: Ratio of lung weight/body weight. Different
stic variable (p < 0.05).
Table 3 Correlation between different lung scorings
Lung
scoring LLS IA LW/LB
SPES†
p < 0.05 p < 0.05 p > 0.05
0 = 0a 0 = 0a 0 = 0.9 [1.4-0.7]a
1 = 2.6 [10-0.3]b 1 = 7.0 [22.9-0.7]b 1 = 1.1 [2.3-0.1]a
2 = 3.7 [6.4-1.1]c 2 = 13.1 [25.8-6.4]c 2 = 1.2 [2.0-1]a
3 = 7.1 [12.2-2.5]d 3 = 26.2 [34.1-14.4] d 3 = 1.3 [1.7-0.8]a
4 = 17.00 [31.4-9.1]e 4 = 52.1 [88.4-33.7]e 4 = 1.7 [2.3-0.9]a
LLS *
p < 0.05 p < 0.05
r = 0.96 r = 0.46
r2 value: 0.93 r2 value: 0.21
IA * *
p < 0.05
r = 0.42
r2 value:0.18
SPES: Slaughterhouse Pleurisy Evaluation System; LLS: Consolidation Lung
Lesion Score; IA: Image analyses; LW/BW: Ratio of lung weight/body weight.
†Mean values and range [Max-Min] of lung scoring within each of the SPES
categories. p values lower than 0.05 means that the pair of lung scoring
system is significantly associated. Different letter in superscript means
statistically significant differences within SPES categories.
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in reducing the number of animals used in future experi-
mental trials (3Rs framework for conducting scientific
animal experiments).
In general terms, a good correlation between all the
lung lesion scoring systems (with the exception of SPES
score versus LW/BW) was observed. SPES, LLS and IA
showed a significant association with the majority of the
variable examined (clinical, production and diagnosticTable 4 Description of the different variables assessed in anim
Variable
Clinical signs Mortality prior to the end of the experiment (%)*
Fever at least one day (%)*
Clinical score higher than 0 (%)*
Mean clinical score (±SD) 1
Inappetence at least one day (%)*
Production Mean ADG (±SD) (kg/d) -
Diagnostic App-like lesions (%)*
App isolation (%)*
PCR detection in tonsil (%)*
PCR detection in bronchial lymph node (%)*
Seropositivity to App at death/necropsy*
Mean SPES (Min-Max)
Mean LLS (Min-Max) 17.5
Mean IA (±SD) 5
Ratio LW/BW (±SD) 0.9
Different letter in superscript means statistically significant differences within a g
SD = standard deviation; *Number of animals showing or being positive by thevariables). In contrast, LW/BW was statistically associ-
ated only with few variables. Thus, the LW/BW score
was the least informative scoring method, most probably
due to the unspecificity of the measure (weight of the
lung, the large variability of the animals within each
group and the low number of animals assessed). How-
ever, the fact that the ratio LW/BW was significantly
higher in App inoculated animals than in their control
counterparts, suggest that this measurement can be also
of interest when the outcome of this disease is evaluated.
In the literature, another lung scoring method based also
on lung weight has been described [15]. In that system,
the weight of the whole lung and the weight of the
pneumonic lung tissue were registered. Probably this lat-
ter system provides much more precise information on
the lung damage, but removal of lung tissue affected by
App-like lesions in cases of pleuritis can be difficult.
Besides, the global analyses of the clinical, production
and diagnostic (including the lung scoring systems) vari-
ables allowed expanding the knowledge on the different
outcomes derived from an App inoculation. For ex-
ample, it was observed that fever due to an App infec-
tion may appear when the App lung lesion score is low
but may last up to five days in those animals with high
lung lesions scores. In contrast, it was also noticed that
not all the acutely affected animals showed fever. More-
over, inappetence was observed as the App lung lesions
score increased. However, there were 10 acutely affected
animals that did not show inappetence through the
entire study. Under field conditions, these clinical signs
(inappetence and fever) are difficult to assess since theals with different courses of disease
Peracute Acute Subclinical Uninfected
(n = 9) (n = 31) (n = 12) (n = 9)
9 (100)a 0 (0)b 0(0)b 0 (0)b
9 (100)a 29 (93.5)a 6 (50)b 2 (22.2)b
9 (100)a 28 (90.3)a 2 (16.6)b 3 (33.3)b
.88 (±0.80)a 1.32 (±0.70)a 0.16 (±0.4)b 0.44 (±0.8)b
9 (100)a 21(67.7)b 3 (25.0)c 2 (22.2)c
1.91 (±0.83)a 0.47 (±0.4)b 0.83 (±0.2)c 0.9 (±0.2)c
9 (100)a 30 (96.7)a 0 (0)b 0 (0)b
9 (100)a 30 (96.7)a 3 (25)b 0 (0)b
8 (88.8)a 18 (58.0)a 10 (83.3)a 0 (0)b
5 (55.5)a 14 (45.1)a 4 (33.3)a 0 (0)b
0 (0)a 16 (51.6)b,c 3 (25.0)a,c 0 (0)a
3.88 (3- 4)a 2.09 (1-4)b 0c 0c
7 (10.71-31.4)a 5.17 (0.26-20.94)b 0c 0c
3.3 (±16.11)a 17.29 (±14.00)b 0c 0c
1(±0. 00)a,b** 1.27 (±0.54)b 0.88 (±0.21)a 0.96a,b (±0.18)
iven variable (p < 0.05). % = percentage; Min = minim; Max = Maximum;
corresponding parameter. **Data available only from one animal.
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in such conditions, these clinical signs are probably
observed for longer periods, especially in the acutely
affected animals that do not die during the outbreak.
Evaluation of the respiratory distress and behaviour
indicated a direct correlation between the clinical score
and the App lung lesion score at necropsy. Nevertheless,
there were five animals showing mild respiratory clinical
scores (score 1 at one or two days after inoculation) that
did not show any apparent App lung lesion at necropsy.
While three of these animals were negative to App
culture, PCR and serology (and therefore classified as
exposed but uninfected), the other two were classified as
subclinically infected pigs because they were positive by
PCR but negative by serology and culture. This situation
confirms the lack of specificity of the diagnoses based
only on clinical signs, especially when these are mild [1].
Another interesting finding is that the SPES score 4
was observed in the lungs of animals affected by per-
acute, but also acute disease. Under field conditions, the
peracutely affected animals would have probably died in
a short period of time after showing clinical signs,
suggesting an App outbreak. In contrast, these acutely
affected animals, although suffered from important App
lung lesions, would have probably developed a subse-
quent chronic App infection.
From a production parameter point of view, reduction
of the ADG was only observed in peracute and acute cases
of porcine pleuropneumonia. Indeed, in the present study,
an App subclinical infection did not exert any effect on
the ADG compared to the non-infected but exposed or
non-challenged counterparts. However, it should be taken
into account that animals were necropsied at 7 dpi and,
therefore, results obtained in regards to ADG cannot be
extrapolated to field conditions. In such situation, App
infection may become chronic or subclinical, lasting for a
longer period of time. In fact, in a previous field study,
App subclinical infections resulted in a decrease of ADG
of 30 g/d from nursery to slaughter [16].
In regards diagnostic variables assessed, a good correl-
ation between presence of App lung lesions and App
isolation from lung samples was obtained. Indeed, bac-
terial isolation from lungs is frequently used to confirm
App involvement in acutely/peracutely affected animals,
but should not be used in chronic infections since it can
lead to false negative results [1]. In such chronic situa-
tions, in which necrosis is seen, the bacteria present in
the lesions might be dead and therefore the isolation
might be negative. This was probably the case of one
acutely affected animal, in which App was not isolated
from the observed lung lesions.
App subclinically infected animals (usually called App
carriers) are usually identified by ELISA or PCR from ton-
sil samples [1,17]. In the present study, the percentage ofsubclinically infected pigs (no App-like lesions but PCR
positive from tonsil samples) was higher than the percent-
age of seropositive animals. This is probably explained by
the short time elapsed between inoculation and necropsy
(maximum of 7 days), which may be also responsible for
the lack of correlation between the lung lesion score
and the seropositivity at the moment of necropsy.
Nevertheless, seroconversion at one week post-infection
has already been described using the same commercial
ELISA kit [18].
At 7 dpi, the rate of App detection by PCR was higher
in tonsils than in bronchial lymph nodes. App PCR in
lymph nodes showed, however, a better correlation with
lung lesion scores than that of tonsil. These results indi-
cate that subclinically infected animals carry App only in
tonsil (reservoir of the bacteria), while peracute and
acutely affected animals, which develop lung lesions,
have the bronchial lymph node also colonized by App.
In agreement with previously published studies, a high
level of individual variation on the challenge outcome
(ranging from fatal cases to uninfected animals) was ob-
served [3,6,19-21]. Indeed, Tobias et al. [4] suggested
that this individual variation may be caused by the non-
homogeneous exposure to the pathogen when the intra-
nasal inoculation is used. However, animals with differ-
ent disease presentations have also been described in
App experimental studies using aerosol [6,22] or intra-
tracheal inoculation [23]. Another fact related with dif-
ferences in the susceptibility to App infection of pigs is
the breeding genetic line [24]. However, this would not
be the case for the present study since, the same source
of animals and the same breeding genetic line were used
in the 6 different trials performed. Other differences
linked to individual susceptibilities, which is a normal
phenomenon in outbred animals, cannot be ruled out.
Conclusions
In conclusion, intranasal inoculation of App serovar 1
led to different outcomes of disease. SPES showed a
statistically significant association with all the clinical,
production and diagnostic (but detection of App in the
tonsil) variables assessed. LLS and IA showed the same
statistically significant associations as SPES with the
exception of seroconversion against App at necropsy.
In contrast, LW/BW was statistically associated only
with App isolation, presence of App-like lesions and
ELISA OD values at necropsy. SPES, LLS and IA are
economic, fast and easy-to-perform lung scoring methods
that in combination with different clinical, productive
and other diagnostic variables allowed the classifica-
tion of such different App outcomes. Taking into ac-
count the difficulty to assess all these methods under
practical conditions, SPES appears to be the most
informative one.
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Additional file 1: Scoring system used to assess the animal clinical
condition throughout the study. Animals with one score of 3 or two
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